UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Tumor Mutation Burden as a Biomarker in Resected Non-Small-Cell Lung Cancer

Journal of clinical oncology, 2018-10, Vol.36 (30), p.2995-3006

2018

Volltextzugriff (PDF)

Subtype Classification of Lung Adenocarcinoma Predicts Benefit From Adjuvant Chemotherapy in Patients Undergoing Complete Resection

Journal of clinical oncology, 2015-10, Vol.33 (30), p.3439-3446

2015

Volltextzugriff (PDF)

Cisplatin, Irinotecan, and Bevacizumab for Untreated Extensive-Stage Small-Cell Lung Cancer: CALGB 30306, a Phase II Study

Journal of clinical oncology, 2011-11, Vol.29 (33), p.4436-4441

2011

Volltextzugriff (PDF)

Single-Agent Versus Combination Chemotherapy in Advanced Non–Small-Cell Lung Cancer: The Cancer and Leukemia Group B (study 9730)

Journal of clinical oncology, 2005-01, Vol.23 (1), p.190-196

2005

Volltextzugriff (PDF)

Effect of Number of Lymph Nodes Sampled on Outcome in Patients With Stage I Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2003-03, Vol.21 (6), p.1029-1034

2003

Volltextzugriff (PDF)

Genomic landscape of non‐small‐cell lung cancer with methylthioadenosine phosphorylase (MTAP) deficiency

Cancer medicine (Malden, MA), 2023-01, Vol.12 (2), p.1157-1166

2023

Volltextzugriff (PDF)

Chemotherapy With or Without Maintenance Sunitinib for Untreated Extensive-Stage Small-Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase II Study-CALGB 30504 (Alliance)

Journal of clinical oncology, 2015-05, Vol.33 (15), p.1660-1665

2015

Volltextzugriff (PDF)

Adjuvant chemotherapy with or without bevacizumab in patients with resected non-small-cell lung cancer (E1505): an open-label, multicentre, randomised, phase 3 trial

The lancet oncology, 2017-12, Vol.18 (12), p.1610-1623

2017

Volltextzugriff (PDF)

Impact of tumor size on survival in stage IA non-small cell lung cancer: a case for subdividing stage IA disease

Lung cancer (Amsterdam, Netherlands), 2003-10, Vol.42 (1), p.51-57

2003

Volltextzugriff (PDF)

Alliance Foundation Trial 09: A Randomized, Multicenter, Phase 2 Trial Evaluating Two Sequences of Pembrolizumab and Standard Platinum-Based Chemotherapy in Patients With Metastatic NSCLC

JTO clinical and research reports, 2021-08, Vol.2 (8), p.100208-100208, Article 100208

2021

Volltextzugriff (PDF)

Phase III Prospectively Randomized Trial of Perioperative 5-FU After Curative Resection for Colon Cancer: An Intergroup Trial of the ECOG-ACRIN Cancer Research Group (E1292)

Annals of surgical oncology, 2023-02, Vol.30 (2), p.1099-1109

2023

Volltextzugriff (PDF)

Smoking Behavior in Patients With Early-Stage NSCLC: A Report From ECOG-ACRIN 1505 Trial

Journal of thoracic oncology, 2021-06, Vol.16 (6), p.960-967

2021

Volltextzugriff (PDF)

Prognostic and predictive effect of KRAS gene copy number and mutation status in early stage non-small cell lung cancer patients

Translational lung cancer research, 2021-02, Vol.10 (2), p.826-838

2021

Volltextzugriff (PDF)

Randomized Phase III Intergroup Trial of Isotretinoin to Prevent Second Primary Tumors in Stage I Non-Small-Cell Lung Cancer

JNCI : Journal of the National Cancer Institute, 2001-04, Vol.93 (8), p.605-618

2001

Volltextzugriff (PDF)

Genome-wide copy number analyses of samples from LACE-Bio project identify novel prognostic and predictive markers in early stage non-small cell lung cancer

Translational lung cancer research, 2018-06, Vol.7 (3), p.416-427

2018

Volltextzugriff (PDF)

Cross-validation analysis of the prognostic significance of mucin expression in patients with resected non-small cell lung cancer treated with adjuvant chemotherapy: Results from IALT, JBR.10 and ANITA

Lung cancer (Amsterdam, Netherlands), 2013-10, Vol.82 (1), p.149-155

2013

Volltextzugriff (PDF)

Prognostic Significance of K-ras Codon 12 Mutations in Patients With Resected Stage I and II Non–Small-Cell Lung Cancer

Journal of clinical oncology, 1999-02, Vol.17 (2), p.668-675

1999

Volltextzugriff (PDF)

Comparative survival after neoadjuvant vs adjuvant systemic therapy in resectable stage II and stage III non-small cell lung cancer: A retrospective study using the National Cancer Database

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.8075-8075

2024

Volltextzugriff (PDF)

Prognostic Significance of Mucin and p53 Expression in Stage IB Non-small Cell Lung Cancer: A Laboratory Companion Study to CALGB 9633

Journal of thoracic oncology, 2010-06, Vol.5 (6), p.810-817

2010

Volltextzugriff (PDF)

Serum CYFRA 21-1 in advanced stage non-small cell lung cancer: An early measure of response

Clinical cancer research, 2003-05, Vol.9 (5), p.1728-1733

2003

Volltextzugriff (PDF)

Outcomes Among African-American/Non-African-American Patients With Advanced Non-Small-Cell Lung Carcinoma: Report From the Cancer and Leukemia Group B

JNCI : Journal of the National Cancer Institute, 2002-02, Vol.94 (4), p.284-290

2002

Volltextzugriff (PDF)

Phase II Trial of Weekly Dose-Dense Paclitaxel in Extensive-Stage Small Cell Lung Cancer: Cancer and Leukemia Group B Study 39901

Journal of thoracic oncology, 2008-02, Vol.3 (2), p.158-162

2008

Volltextzugriff (PDF)

Acute coronary syndrome secondary to fluorouracil infusion

Journal of clinical oncology, 2006-06, Vol.24 (18), p.2959-2960

2006

Volltextzugriff (PDF)

Methyldopa-induced autoimmune haemolytic anaemia revisited

New Zealand medical journal, 2009-08, Vol.122 (1301), p.53-56

2009

Volltextzugriff (PDF)

CASE 2. Meningeal metastases from ovarian carcinoma

Journal of clinical oncology, 2006-02, Vol.24 (6), p.1010-1011

2006

Volltextzugriff (PDF)

1 – 25 von 141

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(134)
Mit Volltextzugriff
(133)

Publikationsform

Artikel
(141)

Sprache

Englisch
(141)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(103)
Humans
(93)
Life Sciences & Biomedicine
(90)
Female
(67)
Male
(62)
Biological And Medical Sciences
(56)
Medical Sciences
(51)
Oncology
(50)
Middle Aged
(49)
Adult
(47)
Aged
(42)
Prognosis
(27)
Lung Neoplasms - Drug Therapy
(25)
Aged, 80 And Over
(22)
Neoplasm Staging
(20)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(19)
Lung Neoplasms - Mortality
(19)
Pneumology
(19)
Respiratory System
(18)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(17)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Tumor Mutation Burden as a Biomarker in Resected Non-Small-Cell Lung Cancer

Subtype Classification of Lung Adenocarcinoma Predicts Benefit From Adjuvant Chemotherapy in Patients Undergoing Complete Resection

Cisplatin, Irinotecan, and Bevacizumab for Untreated Extensive-Stage Small-Cell Lung Cancer: CALGB 30306, a Phase II Study

Single-Agent Versus Combination Chemotherapy in Advanced Non–Small-Cell Lung Cancer: The Cancer and Leukemia Group B (study 9730)

Effect of Number of Lymph Nodes Sampled on Outcome in Patients With Stage I Non–Small-Cell Lung Cancer

Genomic landscape of non‐small‐cell lung cancer with methylthioadenosine phosphorylase (MTAP) deficiency

Chemotherapy With or Without Maintenance Sunitinib for Untreated Extensive-Stage Small-Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase II Study-CALGB 30504 (Alliance)

Adjuvant chemotherapy with or without bevacizumab in patients with resected non-small-cell lung cancer (E1505): an open-label, multicentre, randomised, phase 3 trial

Impact of tumor size on survival in stage IA non-small cell lung cancer: a case for subdividing stage IA disease

Alliance Foundation Trial 09: A Randomized, Multicenter, Phase 2 Trial Evaluating Two Sequences of Pembrolizumab and Standard Platinum-Based Chemotherapy in Patients With Metastatic NSCLC

Phase III Prospectively Randomized Trial of Perioperative 5-FU After Curative Resection for Colon Cancer: An Intergroup Trial of the ECOG-ACRIN Cancer Research Group (E1292)

Smoking Behavior in Patients With Early-Stage NSCLC: A Report From ECOG-ACRIN 1505 Trial

Prognostic and predictive effect of KRAS gene copy number and mutation status in early stage non-small cell lung cancer patients

Randomized Phase III Intergroup Trial of Isotretinoin to Prevent Second Primary Tumors in Stage I Non-Small-Cell Lung Cancer

Genome-wide copy number analyses of samples from LACE-Bio project identify novel prognostic and predictive markers in early stage non-small cell lung cancer

Cross-validation analysis of the prognostic significance of mucin expression in patients with resected non-small cell lung cancer treated with adjuvant chemotherapy: Results from IALT, JBR.10 and ANITA

Prognostic Significance of K-ras Codon 12 Mutations in Patients With Resected Stage I and II Non–Small-Cell Lung Cancer

Comparative survival after neoadjuvant vs adjuvant systemic therapy in resectable stage II and stage III non-small cell lung cancer: A retrospective study using the National Cancer Database

Prognostic Significance of Mucin and p53 Expression in Stage IB Non-small Cell Lung Cancer: A Laboratory Companion Study to CALGB 9633

Serum CYFRA 21-1 in advanced stage non-small cell lung cancer: An early measure of response

Outcomes Among African-American/Non-African-American Patients With Advanced Non-Small-Cell Lung Carcinoma: Report From the Cancer and Leukemia Group B

Phase II Trial of Weekly Dose-Dense Paclitaxel in Extensive-Stage Small Cell Lung Cancer: Cancer and Leukemia Group B Study 39901

Acute coronary syndrome secondary to fluorouracil infusion

Methyldopa-induced autoimmune haemolytic anaemia revisited

CASE 2. Meningeal metastases from ovarian carcinoma

Suchergebnisse filtern